chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient said that she received a headache within 3o mins after receiving the vaccine. Patient became dizzy and just drunk some water. Patient said she that each day her dizziness gets worse. Patient said it hits her when she is walking or in the car. Patient also stated that it feels like she is falling and is starting to become sick to her stomach.
Information has been received from a female patient who on 23-MAY-2007 was vaccinated with a dose of Zostavax (Oka/Merck).  She reported that on 28-MAY-2007, she developed shingles.  A product quality complaint was not involved.  No further information is available.
Day 8 woke up with injection site pain, swollen, hot, itchy.  It continued for 2 weeks.  Day 9 post injection, had vertigo and was taken to the ER.   Day 19 post injection still have elbow pain and a lump on my elbow
Low grade fever; aches; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PYREXIA (Low grade fever) and MYALGIA (aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (Low grade fever) and MYALGIA (aches). At the time of the report, PYREXIA (Low grade fever) and MYALGIA (aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Concomitant product use  was not  provided  Treatment information was not  provided.   Caller's son received vaccinations the same day as caller 27January2021. Son experienced low grade fever aches. Caller did not wish to provide any additional information.   This case was linked to US-MODERNATX, INC.-MOD-2021-138746, US-MODERNATX, INC.-MOD-2021-138764, US-MODERNATX, INC.-MOD-2021-138805 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-138746:caller case US-MODERNATX, INC.-MOD-2021-138764: US-MODERNATX, INC.-MOD-2021-138805:
Pt describes approx 1 day after receiving Pfizer bivalent covid booster, developed enlarged lymph nodes in R axilla, imm given in R arm. Since then lymph nodes waxing/waning but haven't resolved as expected, ongoing discomfort, nodes remain enlarged on exam today largest approx 2cm x 1cm axillary.
Unable to move fingers, arm, shoulder of right extremity due to severe pain. Area from right elbow to shoulder swollen, hard, warm. Experienced nausea due to severe pain level, low grade temp 100.4 treated with Motrin 400mg. Symptoms present from 10/14-10/17/04. Lymph node red, swollen, and warm on right arm, armpit. Recovered 10/18/04.
Narrative: Pt was a 95 YO male with PMH of dementia, DM, GERD, tremors, COPD, BPH, glaucoma, and unspecified blood disorder. Pt date of death reported to facility as 3/12/2021
There was an administration error in which the patient did not receive the full dose of the vaccine because it squirted down her arm. This was resolved by having the patient come back during the same day to receive the remainder of the dose.
Weakness in left arm and tingling in fingers approximately 2 min after vaccine was administered lasting for approximately 30 seconds. About 4 hours later, tingling in fingers again of left arm lasting approximately 1 minute
This spontaneous report as received from a Registered Nurse concerning an unknown number of patients who on an unknown date were vaccinated with a dose of GARDASIL exposed to -1 degrees C for 24 hours (dose, route and lot number not provided). No adverse effects were reported. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age (gender was not reported). On 06-OCT-2013 the patient was vaccinated with an expired dose of PNEUMVOAX 23 (lot # 0217AE, exp. date 22-AUG-2013) (dose and route not reported). No adverse effect reported. It was unknown if the patient sought medical attention or not. Additional information has been requested.
Pt. report left arm stiffness, swelling, redness, lump, itchy at site of injection on the morning following administration. She c/o lightheadedness, nausea, vomiting and diarrhea - constant episodes beginning day after injection until 2 days later when had physician visit. Left arm swollen, warm, hard and red.
Information provided by patient as follows.  It does not appear patient was seen by a provider in the clinic or emergency room.  Besides normal side affects of fever, sore arm, nausea, diarrhea, I have been very itchy and had a rash on the back of both of my thighs as well as all around my belly and head. Also I have been experiencing small spurts of lock jaw and pain in my skull behind my ears.
Itch (no rash) in lower abdomen and genital area, itch, rash, swelling under eyes. Started on Friday 5/7/21, continues to today 5/9/21.
Numb fingers and toes, VERY labored breathing, inability to stay awake,  entire body weakness (unable to lift a water bottle), throat swelling, high fever, chills and body aches, semi-difficulty  breathing
Hospitalization 1/22/22-1/28/22 weakness, fall x 2, productive cough,  hypoxia, CKD III, GI bleed,
Bilateral leg weakness / had to use crutches for weeks / had weakness, numbness / tingling in legs. Still with some symptoms.  1/23/09 Received PCP medical records of 1/6/09 FINAL DX: none provided Records reveal patient experienced back & leg pain, muscle cramps, weakness & tingling since 9/08.  Had traveled out of country 8/08 to remain x 4 mo.  Progressed to legs giving out & needed to use crutches.  Saw neurologist out of country where exam WNL.  MRI of back at that time revealed inflammation SI joint & received PT.  Improved then s/s recurred which did not improve w/additional PT.  Returned home to continue w/u.  No further records available.
Following administration of Pneumovax to left arm, the arm began to swell with redness and tenderness which began within 24 hours of administration. Patient was scheduled to surgery so was given cephalexin prophylactically and reaction was watched closely for any changes.
hearing loss; Information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown age and gender. No information about the pt's medical history, concurrent conditions and concomitant medications was provided. On or about 28-APR-2016, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) as prescribed and/or administered by a pharmacist at a pharmacy for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date, subsequent to the pt's zoster vaccine live (ZOSTAVAX) inoculation, the pt was treated by a physician for hearing loss. As a direct and proximate result of pt's use of zoster vaccine live (ZOSTAVAX), the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the event was considered to be not recovered/not resolved. The reporter considered the event of hearing loss to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the event of hearing loss was determined to be medically significant.
Severe tinnitus -- first time -- while sitting still.  A loud tone, interrupted every few seconds by the sound of my heart beating.  Lasted about an hour.  Since then I've had a minor but noticeable case of tinnitus.
Pt came to pharmacy and reported red rash/bumps on right arm where pneumovax 23 had been given on 8/22/19. While RPH was gathering consent form for additional information on which vaccine had been administered in which arm, Pt walked away and left the pharmacy. No additional information could be obtained. RPH attempted to call patient to counsel on further possible treatment with benadryl and for pt to contact primary provider. Could not reach patient. Left a voice message for them to call back pharmacy. Outcome unknown.
Symptoms started with chest pain and shortness of breath roughly four weeks after vaccination.  Shortness of breath became acute on December 20, 2021.  Patient was advised by primary physicians's office to proceed immediately to ER.  Patient was admitted to the hospital after examination for further diagnostics.   Diagnostics revealed the following: Blood - elevated d-dimer (1.73) ECG - premature supra ventricular complexes but otherwise normal CTA scan - positive for PE with multiple segmental and sub segmental pulmonary emboli throughout all ones of both lungs.  Heart size normal. No evidence of right heart strain.  No acute thoracic aortic pathology.  No focal consolidation.  No pneumothorax or pleural effusion. Ultrasound - positive for DVT in lower right leg.
Patient received MCV4 and PPD around 8:50AM. She was not seen for a visit. After receiving her vaccine and PPD, she remained seated >5 minutes and then collapsed hitting the occipital portion of her skull. 911 was called and parents were notified. Initially her pulse and respirations were steady so no CPR was indicated. We administered 6L O2 by bag mask and connected the AED which advised no shock. She remained unconscious for >10 minutes prior to the arrival of the Fire Dept and ambulance and continued to be unconscious during a portion of her transport. Her vitals remained stable P 70, B/P 130/72, Spo2 100%, R 14, slow, deep, regular. Paramedics from Denver Health took over at 9:13 AM. Pt was transported by ambulance in a C-Collar and Backboard. Contacted Dr to give report. Pt departed by ambulance to  at 9:20 AM still unconscious.  She had awakened by the time she arrived at the ED. Her diagnosis was s/p syncopal ground level fall with + LOC with small right frontal hemorrhagic contusion.  Treatment includes following concussion protocol with multiple visits until patient has progressed through Return to Play. No surgical intervention indicated.
Patient's mother created vaccine profile and appointment and put the wrong birthday date and other false information that allowed patient to receive vaccine. Mother put patient's birth-date as 9/23/1981 instead of 9/04/2004.
Both MMR and Varicella given at 26 days rather than 28 days.
This spontaneous report was received from a medical assistant referring to a 14 year old female patient. The patient's medical history included asthma and seasonal allergy. The patient's concomitant medications were not reported. The patient's drug reactions or allergies include allergy to amoxicillin (rash). On 18-MAR-2019, the patient was vaccinated with PNEUMOVAX 23 intramuscular in left arm, lot number R017475 and expiration date 26-MAR-2020, (dosage schedule date was not reported). On 19-MAR-2019, the patient experienced injection site erythema, pain and a injection site mass on left arm at injection site. The patient received treatment for the symptoms with MOTRIN and TYLENOL and her pharmacist recommended taking BENADRYL. The patient threw up TYLENOL when she took them on an empty stomach. Symptoms did not resolve after these treatments. On 25-MAR-2019, the patient went to see physician because she was still having symptoms. Laboratory diagnostics and studies were performed but the results were not provided. At the time of the report, the patient had not recovered from the events. The causality between the aforementioned events and PNEUMOVAX 23 was not provided.
Dizziness. Extreme muscle weakness. Slurred speech. Giddy laughing replaced by crying. (I always cry when I get a fever, for some reason, so this might be an indication of one.) Sweating. All of this lasted 10-15 minutes. For the rest of the day felt tired, achy, had a constricted throat.
Patient received COVID vaccine Moderna 2 dose series (2/16/21 and 3/16/21). COVID symptoms started on 8/1/21 and he came to our facility Medical Center on 8/9/21 due to worsening symptoms. Patient was tested COVID positive on 8/9/21 upon admission and was admitted to the inpatient setting for COVID PNA with acute respiratory failure. Patient was transferred to CCU on 8/11/21 and intubated on 8/13/21.
Intense stomach cramps that continue for the following days, diarrhea, severe stomach cramps with any food intake.
Information has been received on 08/16/2002 concerning a 12 year old female patient who was vaccinated with a dose of TD ADS ADULT (Lot # U0814AA) IM in the left deltoid.  No date of administration was reported.  Patient developed fever, redness and pain at site of injection.  Patient was diagnosed with cellulitis and treated with Augmentin 500mg twice a day for 5 days.  Outcome was not reported.  See cases U2002-00798 and U2002-00799, same reporter.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 55 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing), notes: other medical history: Hypothyroidism; "post-menopausal" (unspecified if ongoing), notes: other medical history:post-menopausal. Concomitant medication(s) included: SYNTHROID; IMVEXXY. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (31Dec2022) Positive, notes: retested on 31Dec2022 and had a positive test. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
inconsolable crying, per mom - "stuck out tongue, stared off into distance and stiffened up and shook x 2 min.
Rec'd 3rd dose of rotavirus vaccine on 7/6/11. Developed intussusception on 7/18/11. Reduced via air enema.
This spontaneous report was received from a healthcare worker and refers to a 13 month old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions and concomitant therapies was provided. On 02-JUN-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (lot # K010211, expiration date 17-JAN-2016, exact dose and route of administration were not reported). No adverse effects were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same source. Additional information has been requested.
patient got his immunization approx. 8:30 am. mom brought him back to office approx. 11 am with red patchy rash on extremity and trunk. Pt was given oral BENADRYL at that time in the office. Never affected breathing and when mom was called back the next day the rash was gone by that evening (11/12/08).
Makes both arms sore as hell worth it; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Makes both arms sore as hell worth it) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE for Prophylactic vaccination.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Makes both arms sore as hell worth it). At the time of the report, VACCINATION SITE PAIN (Makes both arms sore as hell worth it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  It was unknown if the patient experienced any additional symptoms/events. There were no lab data/results available. It was not reported if the patient received a corrective treatment for the event. The patient's past medical treatment, vaccination, concomitant medication and family history were not provided. There will be no information available on the batch number for this case. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. Most recent FOLLOW-UP information incorporated above includes: On 15-Nov-2021: Significant follow up received included suspect product information updated
5 days later, pt began to feel tired, 13 days later, she had a TIA with hospitalization for 24 hours, a hypertensive emergency, 202/122.
Initially red, very sore, progressed to itching and now a rash has developed below the shot site.
sensory neuropathy; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20Mar2021 at 14:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included peripheral sensory neuropathy. The patient did not have any allergies to food, medications, or other products. Concomitant medications included regular duloxetine (MANUFACTURER UNKNOWN) 30mg and rosuvastatin calcium (CRESTOR) 10mg. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 13:00 the patient experienced sensory neuropathy. It was reported that the patient had a minor sensory neuropathy at the lower extremes before the shot and it clearly flared up after the first shot. It seemed to be better at the time of this report. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event sensory neuropathy was resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
11/19/21-He is fairly healthy for his age, has chronic allergies with allergic rhinitis, worked a day before his symptom onset in his front yard, raking the leaves with mask on.      URI The primary symptoms include nasal congestion and nasal drainage. Primary symptoms do not include fever, headaches, sore throat, cough, wheezing, myalgias or shortness of breath. The current episode started 3 to 5 days ago (4 days). This is a new problem. The problem has not changed since onset. Symptoms associated with the illness include congestion and rhinorrhea. The illness is not associated with chills.  Physical Exam  11/19/21 Vitals and nursing note reviewed.  Constitutional:      General: He is not in acute distress.    Appearance: He is well-developed. He is not diaphoretic.  HENT:     Right Ear: Tympanic membrane and ear canal normal. Decreased hearing noted.     Left Ear: Ear canal normal.     Ears:     Comments: Hearing aid in right ear noted.     Nose: Congestion and rhinorrhea present.     Right Sinus: No maxillary sinus tenderness or frontal sinus tenderness.     Left Sinus: No maxillary sinus tenderness or frontal sinus tenderness.     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: No posterior oropharyngeal erythema.     Tonsils: No tonsillar exudate.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Heart sounds: Normal heart sounds. No murmur heard. Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds. No wheezing.  Musculoskeletal:        General: No deformity. Normal range of motion.  Lymphadenopathy:     Cervical: No cervical adenopathy.  Neurological:     Mental Status: He is alert and oriented to person, place, and time.     Coordination: Coordination normal.  Psychiatric:        Behavior: Behavior normal.   11/19/21-Discussed the lab findings with him, he is referred for Regeneron infusion.  Rest, fluids and other supportive care including supplements (Vit C, Vit D, Zn) and OTC med prn for symptom relief discussed, expected course of illness and recovery time discussed. CDC guidelines for self quarantine and timeframe for RTW
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (159558). The reporter is the patient. A female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer), for COVID-19 Immunization. The following information was reported: CONTUSION (non-serious), outcome "unknown", described as "Bruised up"; BLISTER (non-serious), outcome "unknown", described as "Blisters". Therapeutic measures were taken as a result of contusion, blister. Additional information: A caller had a reaction after getting the vaccine for booster, she had bruised up and blisters. She was prescribed antibiotics for the reactions she had. She would like to know if that was okay after getting the booster. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2nd shot stung a bit unlike 1st one. around 10:30am head felt woozy/slightly dizzy, left work at 1:30pm dizzyness getting a little worst body started aching.  fell asleep for about 30 minutes once home, bed at 9:30pm and started to shake violently like I was freezing but not cold, didn't feel like I had a fever, put on sweatpants and tshirt, turned on elec. blanket, I stopped shaking after about 45 minutes, took acetaminophen and 1 dose of zquil and fell asleep. up at 3:30am in pain, especially my left arm I couldn't lift with pain. called out of work all muscles and joints hurt, less pain with no movement, more acetaminphen  every 6 hrs, started feeling better around 4Am Saturday
pt recvd vax 16AUG95 & the same day exp nausea, dizziness, fatigue & weakness;By 20AUG95 pt recovered;No further details were provided;
Initial and follow up information has been received from a health professional concerning a 10 month (original report was at 4 month) old female child who on 04-MAY-2007 was vaccinated with a dose of PNEUMOVAX 23. In follow up it was reported that on 08-MAY-2007 she was vaccinated with concomitant therapy which included diphtheria toxoid (+) hepatitis B virus vaccine rHBsAg (yeast) (+) pertussis acellular 3-component vaccine (+) poliovirus vaccine inactivated (Vero) (+) tetanus toxoid (lot # AC14B044AA), poliovirus vaccine (lot # Z0547) and Hib conj vaccine (unspecified carrier) (lot # UE958AA). In follow up it was reported that the patient experienced slight redness and swelling which resolved couple days later. No further problems. Additional information is not expected.
patient previously had Pfizer vaccine and requested Pfizer booster but was given Moderna booster